Clinical Trial Update: Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the synergistic immunomodulatory effect of synbiotics administered around surgical resection for pancreatic ductal adenocarcinoma has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Theodor Bilharz Research Institute | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 4 | Status: COMPLETED